---

AI Seoul Summit

I share the sentiments that the hon. Gentleman expressed about my hon. Friend the Member for Bury St Edmunds (Jo Churchill). It was a very sweet thing that he said—the only sweet thing he has said from the Dispatch Box. My hon. Friend has been a great friend to me, giving me advice when I became a new father. Many people do not see the hard work that goes into the pastoral care that happens here, so I am personally very grateful to her. I know that she was just about to leave the Chamber, so I will let her do so. I just wanted to place on record my thanks and gratitude to her.

I am a bit disappointed with the hon. Member for Rhondda (Sir Chris Bryant), although I have a lot of time for him. Let me first address the important matter of healthcare. We obviously hugely focus on AI safety; we have taken a world-leading position on AI safety, which is what the Bletchley and the Seoul declarations were all about.

Ultimately, the hon. Member’s final statement about AI being for humanity is absolutely right. We will continue to work at pace to help build trust in AI, because it can be a transformative tool in a number of different spheres—whether it is in the public sector or in health, as the hon. Member quite rightly pointed out. On a personal note, I hope that, as a cancer survivor he has the very best of health for a long time to come.

Earlier this week, the Prime Minister spoke about how AI can help in the way that breast cancer scans are looked at. I often talk about Brainomix, which has been greatly helpful to 37 NHS trusts in the early identification of strokes. That means that three times more people are now living independently than was previously possible. AI can also be used in other critical pathways. Clearly, AI will be hugely important in the field of radiotherapy. The National Institute for Health and Care Excellence has already recommended that AI technologies are used in the NHS to help with the contouring of CT and MRI scans and to plan radiotherapy treatment and external therapy for patients.

The NHS AI Lab was set up in 2020 to accelerate the development and the deployment of safe, ethical and effective AI in healthcare. It is worth saying that the hon. Member should not underestimate the complexity of this issue .Earlier this year, I visited a start-up called Aival, which the Government helped to fund through Innovate UK. The success of the AI models varies depending on the different machines that are used and how they are calibrated, so independent verification of the AI models, and how they are employed in the health sector specifically, is very important.

In terms of malicious actors, the hon. Member will understand that I cannot go into specific details for obvious reasons, but I assure him, as someone who sits on the defending democracy taskforce, led by the Security Minister, that we have been looking at pace at how to protect our elections. I am confident that we are prepared, having taken a cross-governmental approach, including with our agencies. It is hugely important that we ensure that people can have trust in our democratic process.

The hon. Member is right that these are voluntary agreements. I was surprised by his response, because we said clearly in our response to the White Paper that we will keep the regulator-led approach, which we have invested money in. We have given £10 million to ensure that the regulator increases its capability in a whole sphere of areas. We have also said that we will not be afraid to legislate when the time is right. That is a key difference between what the Opposition talk about and what we are doing. Our plan is working, whereas the Opposition keep talking about legislating but cannot tell us what they would legislate for.